Sort by

Send to

Choose Destination

Search results

Items: 3


Transglutaminase is a therapeutic target for oxidative stress, excitotoxicity and stroke: a new epigenetic kid on the CNS block.

Basso M, Ratan RR.

J Cereb Blood Flow Metab. 2013 Jun;33(6):809-18. doi: 10.1038/jcbfm.2013.53. Epub 2013 Apr 10. Review.


Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemia.

Colak G, Johnson GV.

Neurobiol Dis. 2012 Mar;45(3):1042-50. doi: 10.1016/j.nbd.2011.12.023. Epub 2011 Dec 14.


Transglutaminase 2 protects against ischemic stroke.

Filiano AJ, Tucholski J, Dolan PJ, Colak G, Johnson GV.

Neurobiol Dis. 2010 Sep;39(3):334-43. doi: 10.1016/j.nbd.2010.04.018. Epub 2010 May 6.

Supplemental Content

Loading ...
Support Center